BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2006
View Archived Issues
Positive findings from phase II study of inhaled Parkinson's disease product VR-040
Read More
Introgen to incorporate use of biomarkers in Advexin data analysis
Read More
Takeda sees progress on many fronts in first quarter
Read More
Phase II trials under way at VIA Pharmaceuticals for new antiatherosclerotic candidate
Read More
Cephalon will not pursue Sparlon following not approvable letter
Read More
Medicure acquires Aggrastat from MGI Pharma
Read More
Enrollment reactivated in phase III trial of Riquent
Read More
Abeille submits AB-1001 phase III study protocol for FDA review
Read More
Phase III SLE program announced for LymphoStat-B
Read More
RegeneRx receives grant to support phase II epidermolysis bullosa trial of TB4
Read More
Phase I findings indicate AVR-118 safe in patients with type 2 diabetes
Read More
New antiinfective agents reported in recent patent literature
Read More
Recent patents reveal novel agents for treating endocrine-related disorders
Read More
Recent Janssen and Taiho patents describe new compounds for urological disorders
Read More
Two additional patients treated in phase IIa Oxycyte study
Read More
Positive findings for application of XP-828L platform in atopic dermatitis
Read More
U.K. clearance for phase I study of obesity drug ATHX-105
Read More
Clinical program begins for oral PXD-101
Read More
Arisaph completes second closing of financing round
Read More
Positive phase I data for Actyve transdermal drug delivery for infertility
Read More
Oscient grants Canadian Factive commercialization rights to Abbott
Read More
Bristol-Myers Squibb report on new selective and potent NHE-1 inhibitor
Read More
Bioluminescence imaging used to identify p53 activators
Read More
New prostacyclin receptor agonists developed at Astellas
Read More
Novel family of metabotropic glutamate receptor agonists developed at Faust
Read More